Top Markets
Coin of the day
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
शेयरों में रैंक #39280
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
शेयर मूल्य
$2.06
अंतिम समन्वयन: 2026-08-11
मार्केट कैप
$572.30K
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
-90.38%
देश
CA
व्यापार XORTX Therapeutics Inc. (XRTX)

श्रेणी

XORTX Therapeutics Inc. (XRTX) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $2.06 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $173.60 (2015-10-01 को)
XORTX Therapeutics Inc. के स्टॉक मूल्य का इतिहास 2015 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) -27.44%
2025 -48.32%
2024 -50.05%
2023 -69.00%
2022 -58.91%
2021 105.10%
2020 -34.17%
2019 8.63%
2018 152.77%
2017 -20.67%
2016 22.14%
2015 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$517.18 32.51%
US
$857.76 31.47%
NL
$732.74 7.28%
CH
$1.07K -6.40%
KR
$258.23 14.08%
BE